Business Description
Wuhan Easy Diagnosis Biomedicine Co Ltd
ISIN : CNE1000033Q7
Share Class Description:
SZSE:002932: Class ACompare
Compare
Traded in other countries / regions
002932.China IPO Date
2018-07-10Description
Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 38.27 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.29 | |||||
| Interest Coverage | 6.34 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.4 | |||||
| Beneish M-Score | 3.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -10.5 | |||||
| 3-Year EBITDA Growth Rate | -28 | |||||
| 3-Year FCF Growth Rate | -7.8 | |||||
| 3-Year Book Growth Rate | 71.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.09 | |||||
| 9-Day RSI | 52.55 | |||||
| 14-Day RSI | 52.47 | |||||
| 6-1 Month Momentum % | -14.19 | |||||
| 12-1 Month Momentum % | -29.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.95 | |||||
| Quick Ratio | 2.8 | |||||
| Cash Ratio | 1.29 | |||||
| Days Inventory | 302.62 | |||||
| Days Sales Outstanding | 1403.67 | |||||
| Days Payable | 1792.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 17.84 | |||||
| Dividend Payout Ratio | 8.53 | |||||
| 3-Year Dividend Growth Rate | 387.2 | |||||
| Forward Dividend Yield % | 22.69 | |||||
| 5-Year Yield-on-Cost % | 1420.48 | |||||
| 3-Year Average Share Buyback Ratio | -2.7 | |||||
| Shareholder Yield % | 17.4 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.99 | |||||
| Operating Margin % | 11.62 | |||||
| Net Margin % | 7.2 | |||||
| FCF Margin % | 143.74 | |||||
| ROE % | 0.51 | |||||
| ROA % | 0.4 | |||||
| ROIC % | 0.23 | |||||
| ROC (Joel Greenblatt) % | 7.11 | |||||
| ROCE % | 1.55 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 148.14 | |||||
| PE Ratio without NRI | 47.79 | |||||
| Shiller PE Ratio | 7.01 | |||||
| PEG Ratio | 0.72 | |||||
| PS Ratio | 11.87 | |||||
| PB Ratio | 0.8 | |||||
| Price-to-Tangible-Book | 0.8 | |||||
| Price-to-Free-Cash-Flow | 7.77 | |||||
| Price-to-Operating-Cash-Flow | 6.3 | |||||
| EV-to-EBIT | 38.2 | |||||
| EV-to-EBITDA | 38.2 | |||||
| EV-to-Revenue | 8.82 | |||||
| EV-to-FCF | 6.04 | |||||
| Price-to-Projected-FCF | 0.27 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.91 | |||||
| Price-to-Graham-Number | 1.3 | |||||
| Price-to-Net-Current-Asset-Value | 3.61 | |||||
| Earnings Yield (Greenblatt) % | 2.62 | |||||
| FCF Yield % | 13.06 | |||||
| Forward Rate of Return (Yacktman) % | 40.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wuhan Easy Diagnosis Biomedicine Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 438.097 | ||
| EPS (TTM) (Â¥) | 0.14 | ||
| Beta | 0.07 | ||
| Volatility % | 35.85 | ||
| 14-Day RSI | 52.47 | ||
| 14-Day ATR (Â¥) | 0.764448 | ||
| 20-Day SMA (Â¥) | 20.387 | ||
| 12-1 Month Momentum % | -29.45 | ||
| 52-Week Range (Â¥) | 14.81 - 33.174496 | ||
| Shares Outstanding (Mil) | 232.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wuhan Easy Diagnosis Biomedicine Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wuhan Easy Diagnosis Biomedicine Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Wuhan Easy Diagnosis Biomedicine Co Ltd Frequently Asked Questions
What is Wuhan Easy Diagnosis Biomedicine Co Ltd(SZSE:002932)'s stock price today?
The current price of SZSE:002932 is ¥20.74. The 52 week high of SZSE:002932 is ¥33.17 and 52 week low is ¥14.81.
When is next earnings date of Wuhan Easy Diagnosis Biomedicine Co Ltd(SZSE:002932)?
The next earnings date of Wuhan Easy Diagnosis Biomedicine Co Ltd(SZSE:002932) is .
Does Wuhan Easy Diagnosis Biomedicine Co Ltd(SZSE:002932) pay dividends? If so, how much?
The Dividend Yield %  of Wuhan Easy Diagnosis Biomedicine Co Ltd(SZSE:002932) is 17.84% (As of Today), Highest Dividend Payout Ratio of Wuhan Easy Diagnosis Biomedicine Co Ltd(SZSE:002932) was 11.21. The lowest was 0.02. And the median was 0.33. The  Forward Dividend Yield % of Wuhan Easy Diagnosis Biomedicine Co Ltd(SZSE:002932) is 22.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers